Managing Post COVID-19 Patient with Breathlessness.
Yen Shen WongMuhammad Amin IbrahimMohd Arif Mohd ZimMohammed Fauzi Bin Abdul RaniPublished in: Case reports in medicine (2022)
Corticosteroid inhaler should be cautioned in this case, in view of recent pneumonia and non-elevated serum eosinophil count. These groups of patients should be closely followed up to unmask interstitial lung disease that may present prior to COVID-19 and worsen post-infection. Optimizing pre-existing medical conditions should be the paramount intervention.
Keyphrases
- interstitial lung disease
- coronavirus disease
- sars cov
- systemic sclerosis
- end stage renal disease
- ejection fraction
- randomized controlled trial
- rheumatoid arthritis
- healthcare
- newly diagnosed
- prognostic factors
- idiopathic pulmonary fibrosis
- peritoneal dialysis
- case report
- peripheral blood
- patient reported outcomes